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Loss of oligodendrocytes is a feature of many demyelinating diseases including multiple sclerosis. Here, we have established and char-
acterized anovelmodel of genetically induced adult oligodendrocyte death. Specific primary loss of adult oligodendrocytes leads to awell
defined and highly reproducible course of disease development that can be followed longitudinally by magnetic resonance imaging.
Histological andultrastructural analyses revealedprogressivemyelin vacuolation, inparallel to diseasedevelopment that includesmotor
deficits, tremor, and ataxia.Myelin damage and clearancewere associatedwith induction of oligodendrocyte precursor cell proliferation,
albeit with some regional differences. Remyelination was present in the mildly affected corpus callosum. Consequences of acutely
induced cell death of adult oligodendrocytes included secondary axonal damage. Microglia were activated in affected areas but without
significant influx of B-cells, T-helper cells, or T-cytotoxic cells. Analysis of the model on a RAG-1 (recombination activating gene-1)-
deficient background, lacking functional lymphocytes, did not change the observed disease and pathology compared with immune-
competent mice. We conclude that this model provides the opportunity to study the consequences of adult oligodendrocyte death in the
absence of primary axonal injury and reactive cells of the adaptive immune system. Our results indicate that if the blood–brain barrier is
not disrupted, myelin debris is not removed efficiently, remyelination is impaired, and axonal integrity is compromised, likely as the
result ofmyelin detachment. Thismodel will allow the evaluation of strategies aimed at improving remyelination to foster axon protection.
Introduction
Altered interactions betweenmyelinating glia and the underlying
axon, originating in the glial cell, are often at the heart of disease-
associated axonal degeneration in the peripheral nervous system
and CNS. This observation is prevalent in hereditary motor and
sensory neuropathies (Suter and Scherer, 2003), in Pelizaeus–
Merzbacher disease/spastic paraplegia type-2 due to proteolipid
protein 1 (PLP1) mutations, and mouse models thereof (Nave
and Trapp, 2008; Nave, 2010). Immunological components may
accentuate the disease phenotypes (Martini and Toyka, 2004;
Kroner et al., 2010). A particular example in this regard is multi-
ple sclerosis (MS) (Compston and Coles, 2008). Historically, the
emphasis of research in this disease has been on its inflammatory
aspects. Today, the opinion predominates that primary demyeli-
nation due to autoimmunemechanisms is followed by secondary
axonal degeneration. The latter is the cause of irreversible neuro-
logical disability, although it has been questioned recently
whether inflammatory demyelination is primary or secondary to
neurodegeneration (Trapp and Nave, 2008). MS-associated de-
myelination may also be caused by different mechanisms in dif-
ferent patients and variable sclerotic plaques, including T-cell- or
antibody-mediated demyelination, or primary oligodendrocyte
(OLG) cell death (Lucchinetti et al., 2000; Barnett and Prineas,
2004; Barnett and Sutton, 2006).
A genetic mouse model in which intrinsic adult OLG death
could be induced in a highly controlled and specific fashion may
have major benefits. First, such mice could serve as a valuable
animal model of demyelination, in which primary OLG loss oc-
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curs without concurrent effects on axons that are a likely feature
of toxin-based models of demyelination. Second, the model may
allow studies on the dynamics of myelin clearance and microglia
activation after defined OLG death, both major determinants of
remyelination (Kotter et al., 2006; Neumann et al., 2009). This is
considered to be a critical issue for axon protection (Franklin and
Ffrench-Constant, 2008). Third, the potential role of the immune
system in the developing disease and pathology can be examined.
Fourth, the well developedmouse genetics provide ample oppor-
tunities to study the function of different regulatory proteins in
the process ensuing induced adult OLG death by appropriate
cross-breeding. Fifth, the model is likely to provide novel oppor-
tunities to study the mechanistic basis and signaling that is in-
volved in axon–glia interactions, including axonal degeneration
secondary to OLG death, in health and disease.
To achieve our goal, we used a tamoxifen (TAM)-dependent
PLPCreERT2 allele (Leone et al., 2003) in combination with an
improved allele carrying a Cre-dependent diphtheria toxin frag-
ment A (DT-A) transgene in the ubiquitously expressed ROSA26
locus (Brockschnieder et al., 2006). Double-transgenic animals
treatedwith TAM turned out to havemany of the desired features
and are analyzed here.
Materials andMethods
Generation, maintenance, treatment, and scoring of mice
The previously characterized mouse lines PLP–CreERT2 (Leone et al.,
2003) and R26:LacZ/DT-A (Brockschnieder et al., 2006) were crossed to
obtain amodel allowing spatially and temporally controlled induction of
OLG cell death. The mouse lines PLP–CreERT2 (Leone et al., 2003) and
Cre-dependent R26R-eYFP (Srinivas et al., 2001) were crossed to analyze
recombination efficiency. Mice were housed under a normal light/dark
cycle (12 h) with standard rodent chow and tap water ad libitum. Geno-
types were determined by PCRon genomicDNAderived from ear punch
biopsies according to published protocols (Leone et al., 2003; Brock-
schnieder et al., 2006). Mice at the age of 8–12 weeks were used. Induc-
tion of DT-A or yellow fluorescent protein (YFP) expression was
achieved by intraperitoneal injections of 2 mg of TAM (Sigma-Aldrich),
dissolved in a sunflower oil/ethanol mixture (10:1), for 5 consecutive
days (first injection day 1). Mice were monitored regularly, and their
impairments assessed with a specially developed clinical scoring proce-
dure, broadly modeled after scorings used in experimental autoimmune
encephalomyelitis (EAE) (Matthaei et al., 1989) (score 0, no observable
symptoms; score 1, tremor and ataxia, broadened gait, and reduced grip
strength; score 2, severe hindlimb weakness plus pronounced ataxia and
tremor; and score 3, animals temporarily fail to maintain upright posi-
tion, and both front and hind limbs showed severe weakness). Transition
states were scored with half steps. Investigated time points were defined
as follows: onset, day 20 referring to first observable impairments (score
0.5); intermediate, day 34 referring to moderate impairments (score
1.5); end stage, days 39–42 when mice reached the strongest impair-
ments (score 3). To obtain a more quantitative measure of behavioral
abnormalities, mice were placed on a rotarod apparatus (TSE Systems),
and the time spent on the rotating rod while accelerating from 4 to 40
rpm was measured. Three trials per day in 4 h intervals were performed
every 3–4 d throughout the disease time course. EAE was induced in
C57BL/6j mice by immunization against MOG35-55 peptide according
to standard protocols (Mendel et al., 1995). Proliferating cells were la-
beled by injections of iododeoxyuridine (IdU) (80 g/g body weight)
three times daily for 5 consecutive days followed by a 5 d washout period
before killing. All experiments were performed in strict adherence to the
Swiss Law for Animal Protection, approved by the veterinary office of the
Canton, Zu¨rich, Switzerland.
Magnetic resonance imaging
During the time course of disease development, animals were analyzed
with regard to changes in the T2 relaxation time. For quantitative T2
(qT2), which started at day 3 following induction of gene expression,
mice were anesthetized using 1.8% isoflurane (Abbott) in an oxygen/air
(20%/80%) mixture applied via a facemask with built-in teeth-bar and
placed on a water-heated cradle. Body temperature was monitored using
a rectal probe coupled to a fluor optic module (QUASYS AG). Magnetic
resonance imaging (MRI) acquisition was performed using a Phar-
mascan 4.7/16 system (Bruker BioSpin) equipped with a birdcage
transmit–receive coil for assessment of qT2. T2 values were obtained
using a multi-spin echo sequence with the following parameters: field-
of-view (FOV) 19 19mm;matrix dimension 132 132; in-plane
resolution, 144 m2; repetition time  2000 ms; echo time  10 ms;
echo spacing 10.0 ms; no. of echoes, 14; no. of averages 6; and slice
thickness 0.8mm. T2maps were calculated using Biomap (M. Rausch,
Novartis). Maps from the same animal were coregistered, and T2 values
were plotted as a function of time for the defined regions of interest
(ROIs) [frontal cortex (fx), cerebellar white matter (cb), brainstem (bs),
anterior commissure (ac)] (Fig. 1D). All data are given as mean SEM.
Data were statistically analyzed using repetitive ANOVA (n 2 control
and 4 experimental animals).
Tissue preparation
Mice were deeply anesthetized using 150 mg/kg pentobarbital (Esconar-
kon, Streuli Pharma AG) and transcardially perfused with heparin (250
mg/L, Sigma-Aldrich) in PBS followed by fixation with 4% paraformal-
dehyde/PBS (Sigma-Aldrich) for light microscopy or with 3% glutaral-
dehyde and 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for
electron microscopy. Brain and spinal cord tissues were dissected and
postfixed overnight at 4°C. For paraffin sectioning, tissues were dehy-
drated, embedded in paraffin (Medite), sectioned into 5 m coronal or
sagittal sections using a rotary microtome (HM355S, Microm), and
taken up on polysine-coated glass slides (Menzel). For cryosectioning,
tissues were cryoprotected with 30% sucrose/PBS at 4°C overnight, em-
bedded in OCT (Medite), sectioned into 10 m sections using a cryostat
(HM560, Microm), and taken up on Superfrost Plus glass slides (Men-
zel). For semithin and ultrathin resin sectioning, tissues were postfixed
and contrasted with 2% osmium tetroxide (EMS), dehydrated with ace-
tone, embedded in corrected Spurr’s resin (EMS) (Ellis, 2006), sectioned
into 0.5mor 80 nm sections using a finemicrotome (Ultracut E, Leica),
and taken up on standard glass slides (Menzel) or copper EM grids
(EMS). Semithin sections for light microscopy were contrasted with 1%
toluidine blue (Sigma-Aldrich), and ultrathin sections for electron mi-
croscopy were contrasted with 3% uranyl acetate and 1% lead citrate.
Light microscopy
Luxol-Fast-Blue (LFB) and Luxol-Nissl (L-N) stainings were executed
according to standard procedures. In short, sections were deparaffinized,
rehydrated to 95% alcohol, heated in 0.1% LFB (Sigma-Aldrich) in a
microwave, and differentiated with 0.05% lithium carbonate (Sigma-
Aldrich) and alcohol. For L-N, counterstaining with cresyl violet acetate
was used (Sigma-Aldrich). For Oil Red-O staining, cryosections were
postfixed, incubated in 60% isopropanol, stained in Oil Red-O staining
solution [0.3% Oil Red-O (Sigma-Aldrich) in 60% isopropanol] for 20
min, and washed in 60% isopropanol and H2O. For costainings, Oil
Red-O staining was performed after incubation with ABC reagent mix.
Fluoro-Jade C staining was executed according to published protocols
(Schmued et al., 2005). For immunohistochemistry on paraffin sections,
samples were deparaffinized, rehydrated, and exposed to heat-mediated
antigen retrieval using a tissue microwave oven (Medite). Endogenous
peroxidase was blocked with 3% H2O2/methanol (Sigma-Aldrich), fol-
lowed by blocking and permeabilization with blocking buffer [10% fetal
calf serum (Brunschwig), 1% bovine serum albumin, and 0.1% Triton
X-100 (both Sigma-Aldrich) in PBS], and incubation with primary anti-
bodies [rat-anti-myelin basic protein (MBP), 1:300; AbD, Serotec),
rabbit-anti-degMBP (1:1000; Millipore), rabbit-anti-neurofilament M
(NF-M) (1:300; Millipore), rabbit-anti-Iba-1 (1:300; WAKO Chemi-
cals), rabbit-anti-GFAP (1:500; Dako), rat-anti-B220 (1:200; BD Bio-
sciences), rat-anti-CD4 (1:200; BD Biosciences), and rat-anti-CD8 (1:
200; BD Biosciences)] overnight at 4°C in blocking buffer. Sections were
washed, incubated with corresponding biotinylated secondary antibod-
ies (1:500; Jackson ImmunoResearch) followed by incubation with Vec-
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tastain ABC reagent mix (Reactolab), and developed with DAB metal
enhancer solution (Thermo Scientific). Sections were counterstained
with cresyl violet acetate and dehydrated.
For immunofluorescence on cryosections, samples were postfixed with
4% paraformaldehyde followed by blocking and permeabilization with
blocking buffer [10% fetal calf serum (Brunschwig), 1%bovine serumalbu-
min, and 0.1% Triton X-100 (both Sigma-Aldrich) in PBS]. Sections were
then incubated with primary antibodies [goat-anti-Sox10 (1:50; Santa Cruz
Biotechnology), rabbit-anti-Olig2 (1:500; Millipore), rabbit-anti-NG2 (1:
500; Millipore), mouse-anti-IdU (1:50; BD Biosciences), rabbit-anti-GFP
(1:200; Invitrogen), rabbit-anti-NF-M (1:300, Millipore), mouse-anti-
nonphosphorylated neurofilaments (SMI32; Abcam), mouse-anti-amyloid
precursor protein (APP) (1:400;Millipore), Fluoro-Jade C (0.0001%;Milli-
pore), mouse-anti-Caspr (1:400; NeuroMab), and mouse-anti-Kv1.2
(1:200;NeuroMab]overnight at 4°C inblockingbuffer. For IdU/Olig2 stain-
ings, sections were exposed to antigen retrieval according to IdU supplier
recommendations before antibody incubation. Sections were washed, incu-
bated with corresponding fluorescence-coupled secondary antibodies (1:
500; Jackson ImmunoResearch), and counterstained with DAPI (Sigma-
Aldrich). Stained and processed sections were documented using an
AxioImager Microscope and an AxioCamMRc5 (Zeiss). Image Processing
was performed using Axiocam (Zeiss) and Photoshop (Adobe Systems).
Electron microscopy
Contrasted ultrathin resin sections were documented using a Morgani
268 transmission electron microscope (FEI). Image Processing was per-
formed using Photoshop (Adobe Systems).
Evans blue permeability assay
Influx of Evans blue-labeled serum albumin into brain tissue was as-
sessed according to published procedures (Ogunshola et al., 2006). In
short, a 1% solution of Evans blue dye (2 g/g) was injected intrave-
nously 1 h before killing. Mice were anesthetized and transcardially per-
fused with PBS, and brain tissue dissected. Dye retained in the tissue was
extracted with formamide, and absorbance was measured at 620 nm.
Quantifications
Vacuole counting.Tissue vacuoles were blind countedmanually onMBP-
stained paraffin sections on images acquired at 40magnification using
ImageJ counting software (open source software: http://rsbweb.nih.gov/
ij/), counting eight random FOVs on four different sectioning levels per
tissue of interest. Data are given asmean SEMand statistically analyzed
using Student’s t test (n 3 animals).
Counting of Sox10 cells and recombination efficiency. Sox10 cells
were blind counted manually on Sox10/DAPI-, SOX10/YFP/DAPI-, or
NG2/YFP/DAPI-stained sections on images acquired at 10magnifica-
tion using ImageJ, counting four randomFOVs on two different section-
ing levels per tissue of interest. Data are given as mean  SEM and
statistically analyzed using Student’s t test (n 3).
Counting of proliferating oligodendrocyte precursor cells. Proliferative
oligodendrocyte precursor cells (OPCs) were blind countedmanually on
Olig2/IdU/DAPI-stained sections on images acquired at 40magnifica-
tion using ImageJ, counting 10 random FOVs on at least three different
sectioning levels per tissue of interest. Data are given asmean SEMand
statistically analyzed using Student’s t test (n 3).
Analysis of g-ratios. Corpus callosum g-ratios were determined from
100 healthy-appearing myelinated axons per animal on electron mi-
crographs by manually measuring the areas of axon and myelin using
Photoshop and calculating g-ratio  (axon area/fiber area). Data were
Figure1. Genetic basis and longitudinal assessment of disease development after induction
of adult oligodendrocyte cell death. A, Genetic basis for spatially and temporally controlled
ablation of adult OLGs. The inducible PLP–CreERT2 line was crossed with the Cre-dependent
R26:lacZ/DT-A line to ablate OLGs after TAM injection.B,B, Time course of clinical appearance
in 2–3-month-old PLP–CreERT2/DT-A double-transgenic mice, with or without TAM injec-
tions, as judged by clinical scoring (B) and correlative performance in the rotarod test (B). C,
4
Quantitative MRI T2 maps of a representative animal during the time course of disease devel-
opment after TAM injections. Note the pronounced hyperintensities in cerebellar core white
matter (arrowheads), but also inbrainstemandmidbrain, first detectablebutnot yet significant
around symptomatic onset (day23).D, Representative T2mapwith superimposedROIs used for
quantifications. E, Quantitative T2 values derived from ROIs in cb, bs, ac, and fx. Significance in
the increase of T2 relaxation times was reached at day 37 in the analyzed white matter (cb, bs,
and ac) but not graymatter (fx) regions. Data are given asmean SEM. *p 0.05, repetitive
ANOVA.
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dot plotted or given as mean  SEM and statistically analyzed using
Student’s t test (n 3).
Analysis of SMI32 immunofluorescence. SMI32 immunofluorescence
intensity was measured on images acquired at fixed settings of SMI32-
stained cryosections of cerebellar core area at 20 magnification using
four FOVs on two different sectioning levels per animal. Images were
analyzed using ImageJ. Mean intensity was calculated by dividing mean
gray values by the area above a threshold value. Image intensity threshold
was set to exclude background signal. Mean of controls was set to 1, and
data are given as mean  SEM of relative staining intensity and were
statistically analyzed using Student’s t test (n 3).
Counting of nodes of Ranvier. Caspr- or Kv1.2-stained spinal cord sec-
tions were imaged at 63magnification at two different focal planes per
FOV, using five random FOVs per animal. The two focal planes were
overlaid using Photoshop, and the specific pattern of Caspr paranodes
or Kv1.2 juxtaparanodes were identified and counted manually in a
blindedmanner.Data are given asmean SEMand statistically analyzed
using Student’s t test (n 3).
Quantification of microglia. Iba-1 cells were blind counted manually
onMBP-stained paraffin sections on images acquired at 40magnifica-
tion using ImageJ, counting six FOVs on two different sectioning levels.
Data are given as mean SEM and statistically analyzed using Student’s
t test (n 3).
Results
Characterization of behavioral changes of a genetically
controlled mouse model of induced adult oligodendrocyte
cell death reveals a highly consistent disease development
Our aim was to establish a mouse model that allowed defined
induction of genetically controlled cell death of adult OLGs. To
achieve this, we crossed a mouse line carrying an optimized
TAM-inducible version of Cre (CreERT2), under PLP gene tran-
scriptional control (Leone et al., 2003), with a mouse line con-
taining a Cre-dependent DT-A expression cassette (Fig. 1A)
(Brockschnieder et al., 2006). Double-transgenic offspring were
treated with 2 mg/d TAM for 5 consecutive days at the age of 2–3
months (young adults). These animals developed a highly con-
sistent disease course, regarding onset of clinical signs and pro-
gression (Fig. 1B), as evaluated using a specifically developed
scoring assay (see Materials and Methods). Such clinical changes
were never observed in control animals (vehicle-injected double-
transgenic animals or TAM-treated single-transgenic animals of
eithermouse line; data not shown). Clinical progression in TAM-
treated double-transgenic animals (henceforth referred to as “ex-
perimental mice”) was characterized by an initial lag period of 3
weeks without evident disease signs. Around 21 d after injection
start, the experimental mice showed increasing tremor and
ataxia, motor deficits accompanied by muscle atrophy, and
weight loss. The severity of disability increased steadily over the
next 3 weeks, and the animals could not be kept longer onwelfare
grounds. To obtain a quantitative measure of the increasing def-
icits, we analyzed experimental and control mice using the ro-
tarod test (Fig. 1B). The results mirrored our clinical scoring,
thus confirming the strikingly uniform and steady time course of
disease progression. Thus, our data show that induced cell death
of adult OLGs generates a defined and clinically highly reproduc-
ible mouse phenotype.
Longitudinal magnetic resonance imaging is a suitable
method to follow the consequences of adult oligodendrocyte
loss
Following pathological changes longitudinally in the same living
animal hasmany self-evident experimental advantages.We chose
to examine whether this is feasible in our experimental mice by
carrying out serial MRI assessing quantitative T2 values through-
out disease progression. Parasagittal T2 maps obtained from ex-
perimental animals showed consistent alterations over the time
course of disease progression as evidenced by increasing hyper-
intensities in distinct brain areas (Fig. 1C). Qualitative evalua-
tions revealed first effects around disease onset at day 23,
especially pronounced in cerebellar core white matter, brainstem
regions of pons and medulla, and midbrain (Fig. 1C). Quantifi-
cations of T2 relaxation times in defined ROIs (Fig. 1D) revealed
no alterations in control mice across the longitudinal study with
average T2 values of 55  3 ms. T2 values of the experimental
group increased over time (i.e., with values for the cerebellar ROI
changing from a baseline of 54 0.5 to 68 1 ms at end stage).
This pronounced increase in T2 matches disease progression in
white andmixedmatter tissues including cerebellar core, anterior
commissure, and brainstem, but was not detectable in gray mat-
ter regions like frontal cortex (Fig. 1E). Dilation of ventricles was
not an obvious contributing feature, although we cannot exclude
occasional minor effects. We did not observe significant changes
of T2 values in the various brain regions of controlmice through-
out the observation period. We conclude that longitudinal MRI
analysis is suitable to follow impairments due to induced loss of
OLGs in time and space in accordance with the observed disease
development time course. Thus, this method can potentially be
used to examine the benefits of experimental treatment strategies
aimed at replacing the lost OLGs either by activating resident
stem/precursor cells or by transplantation.
Acute loss of adult oligodendrocytes leads to
myelin vacuolation
To assess changes in tissuemorphology in our experimental mice
and to correlate these to the behavioral and imaging data, we
performed immunostaining at representative time points of phe-
notypic development: before TAM-mediated induction; at onset
of clinical signs at day 20, intermediate stage at day 34, and end
stage at days 39–42 (Fig. 2). First, we examinedmyelin by immu-
nolabeling for MBP. Myelin staining was progressively reduced
over time in the cerebellar white matter, brainstem, midbrain,
and spinal cord white and gray matter (Fig. 2A). We also ob-
served a widespread progressive vacuolation (status spongiosus)
in white matter that was present at the onset of clinical signs and
increased in size and number over time (Figs. 2A, 3A,B). Next,
we examined neurons using NF staining, which revealed a pro-
gressive loss of staining intensity. These findings are consistent
with secondary axonal damage due to primary loss of adult OLGs
and the associated myelin alterations (Fig. 2B).
The severity of vacuolation differed throughout the neu-
roaxis. Most severely affected were the cerebellar white matter,
brainstem, and spinal cord white matter, while the spinal cord
gray matter showed no prominent vacuole load (Fig. 3A). Anal-
ysis of vacuoles in the severely affected regions of cerebellar white
matter and brainstem showed a steady increase over time, in
parallel to the progression of clinical signs (Fig. 3B). Interestingly,
myelinated regions of the forebrain were variably affected, being
especially severe in the anterior commissure while the corpus
callosum was only mildly altered at end stage (Fig. 3A).
To determine the cellular origins of the status spongiosus
(Adornato and Lampert, 1971), we analyzed first toluidine blue-
stained resin sections. As shown in the representative region of
the spinal trigeminal tract of experimental mice (Fig. 3C), the
observed tissue abnormalities were similar in distribution to
those revealed by myelin staining (Fig. 2A). Vacuoles were re-
stricted to single myelin lamellae at initial stages, but over time
the expanding vacuoles caused widespread tissue disruption. Ul-
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Figure 2. Histological assessment of brain and spinal cord tissue after induction of adult oligodendrocyte loss. A, MBP staining on brain sagittal sections (left) and spinal cord cross
sections (right) at different time points of disease progression. Note the reduced MBP staining over time, most pronounced in cerebellar core white matter and brainstem (arrows). A,
Magnifications of cb and bs regions show reductions of myelin staining over time and remarkably increasing tissue vacuolation. B, NF staining on brain sagittal sections (left) and spinal
cord cross sections (right) at different time points of disease progression. Note the reduced NF staining intensity in impaired regions, especially at end stage. Scale bars: A, B, brain
overviews, 1 mm; A, B, spinal cord sections, 200m; A, 20m.
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trastructural analysis confirmed that vacuolation was due to al-
teration of myelin membranes (Fig. 3D). Vacuoles arose due to
splitting at various places within the myelin sheath, between the
axolemma and the myelin sheath, or by a combination of both.
Membrane splitting and vacuolation occurred locally along the
internode, with the rest of the myelin sheath remaining compact
(Fig. 3D). In summary, experimental mice show major progres-
sive myelin vacuolation in parallel with the development of clin-
ical signs.
Efficient elimination of oligodendrocytes by genetically
induced cell death triggers oligodendrocyte precursor
proliferation
To determine the efficacy of induction of OLG cell death in our
experimental animals, we used the pan-oligodendrocyte lineage
marker Sox10 (Wegner, 2001; Rivers et al., 2008). OLG densities
varied markedly between different CNS regions in control ani-
mals (supplemental Table 1, available at www.jneurosci.org as
supplemental material). Quantification revealed a decrease of
Sox10 cells in affected areas in experimental animals at end
stage (reductions ranged between 60 and 80%) (Fig. 4A). We
selected cerebellar white matter (reduction of 78 5.3%), brain-
stem (reduction of 55 6.7%), and corpus callosum (reduction
of 65  2.8%) for further analysis due to their differences in
Sox10 cell numbers and morphology at end stage. We found a
significant reduction of Sox10 cells already 3 d after the start of
TAM injections, with progression at 6 d, and lowest observed
levels reached at 11 d (80% reduction in all three regions ex-
amined) (Fig. 4B). These results are in line with the recombina-
tion efficiencies found in the same areas using the Cre-dependent
R26:eYFP reporter mouse line in combination with the PLP–
CreERT2 transgene and identical TAM regimens as in experi-
mental mice (Fig. 4E). In the same experimental setting, we
found 30% of NG2 OPCs to be recombined, indicating that
this population is also affected (Fig. 4F). We do not know
whether this ubiquitous minor loss of OPCs contributes to the
resulting phenotype. After disease onset, changes in Sox10 cell
numbers varied between different regions in experimental mice.
The severely affected cerebellar white matter showed no signifi-
cant increase in Sox10 cell density, while in the similarly af-
fected brainstem, Sox10 cells increased significantly between
intermediate and end stage. The weakly affected corpus callosum
showed a significant increase between onset and intermediate
stage. Next, we asked whether the observed increases in Sox10
cells might be due to increased OPC proliferation. Thus, we
labeled cells with IdU injections, starting 10 days before killing
at end stage, and quantified IdU-Olig2 double-positive OPCs.
Proliferating Olig2 cells were highly increased in most af-
fected areas (cerebellar white matter, brainstem, and anterior
commissure) but not in the mildly affected corpus callosum or
in the strongly affected spinal cord white matter (Fig. 4C,D).
Thus, the genetic cell ablation is synchronous and consistent
between the different areas that we examined, but subsequent
pathology development, including induction of OPC prolifer-
ation, varies to some degree.
Figure 3. Tissue vacuolation after induction of adult oligodendrocyte death. A, Tissue vacu-
olation at end stage of mice affected by genetically induced OLG cell death: cb, bs, ac, corpus
callosum (cc), spinal cordwhite (spcwm), and gray (spc gm)matter, and fx.B, Accumulation of
vacuoles is most prominent in severely affected white matter tissues, and vacuoles appear and
increase in numbers during disease development as quantified by manual counting on histo-
logical sections. C, Morphology of representative spinal trigeminal tract regions of the brain-
stem on toluidine blue-stained resin sections. Vacuoles appear in parallel to clinical signs and
increase in both size and numbers while impairment of themice progresses.Widespread tissue
vacuolation is observed at end stage. Note the abundance of disrupted, degenerative, but not
4
yet clearedmyelin.D, Electronmicrographsof vacuolated tissue reveal pronounced status spon-
giosus ofmyelin sheaths appearing adaxonal, withinmyelin layers, or even affecting the entire
myelin sheath. Vacuolation can also be a local event along an internode. Data are given as
mean SEM. *p 0.05, **p 0.01, ***p 0.001, Student’s t test. Scale bars: C, 20m;D,
2m.
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Slow removal of myelin debris in
affected areas and
impaired remyelination
Myelin changes and proliferation ofOPCs
are often associated with the regenerative
process of remyelination. We therefore
undertook a detailed electron micro-
scopic analysis of affected tissue since this
provides the most reliable means of de-
tecting the thin myelin sheaths typical of
remyelination. Even at end stage, large
quantities of partially disrupted myelin
debris were present (Fig. 3C,D). These
findings were corroborated with immu-
nostains revealing widespread degener-
ated myelin, using an antibody that
detects specifically an MBP epitope un-
masked during myelin degeneration (Ta-
kahashi et al., 2007) (supplemental Fig.
3C, available at www.jneurosci.org as sup-
plemental material). In all affected white
matter areas, we frequently found phago-
cytic cells involved in myelin debris clear-
ance, as indicated by myelin debris-filled
vacuoles within their cytoplasm (Fig. 5A),
a finding further confirmed as widespread
by Oil Red-O/Iba-1 double stainings
(supplemental Fig. 3A,B, available at
www.jneurosci.org as supplemental ma-
terial). Furthermore, denuded axons were
observed (Fig. 5B), although the majority
of axons were still associated with dis-
rupted myelin (Fig. 5D) or, less often,
normal-appearing myelin. Occasionally,
we found abnormally thin but normal-
appearing myelin sheaths indicative of re-
myelination (Fig. 5C). However, such
remyelinated fibers were sparse and dis-
persed. Loss of myelin sometimes affected
only individual internodes along a given
axon, as indicated by the presence of oc-
casional heminodes (Fig. 5E). In the cor-
pus callosum, quantitative analysis of
g-ratios revealed no significant difference
in experimentalmice comparedwith con-
trols (0.71  0.005 vs 0.70  0.004), al-
though g-ratios 0.8 were only found in
experimental mice (10.3%  2.62 vs
2.04% 1.09 in control, p 0.044) (Fig.
Figure 4. Loss of oligodendroglia and oligodendrocyte precursor proliferation. A, Loss of Sox10 oligodendrocytic cells fol-
lowing TAM-mediated recombination and subsequent cell-intrinsic expression of DT-A in various CNS areas: cb, bs, ac, corpus
callosum (cc), spinal cord white matter (spc wm), spinal cord gray matter (spc gm), and fx at end stage of clinical development
compared with control mice. Sox10 cell numbers are strongly diminished with the exception of the fx. B, Reduction of oligo-
dendroglial cells starts immediately after TAM-induced recombination and reaches the lowest point at day 11. Numbers remain
lowwith some increases in bs and cc at late time points. C, Proliferating Olig2OPCs in the anterior commissure after labeling for
5 consecutive days with a thymidine analog, starting 10 d before killing at end stage. Arrowheads mark proliferating OPCs. Inset,
4
Single optic confocalmicroscopy section of exemplary double-
positive cell. D, Quantification of proliferative OPCs shows an
increase in all areas analyzed (cb, bs, ac, and spcgm), aswell as
in cc and spc wm, at end stage but not at day 11 after start of
TAM treatment. E, Recombination efficiencies are comparable
between different CNS regions when analyzed with a PLP–
CreERT2/Cre-dependent R26:eYFP reporter mouse and the
routine TAM injection protocol. F, Using the same experimen-
tal setup as in E, recombination is observed in a fraction of
OPCs, comparable between theCNS regions analyzed. Data are
givenasmeanSEM.*p0.05, **p0.01, ***p0.001,
Student’s t test. Scale bar, 50m.
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5H). Axonal diameters of myelinated ax-
ons did not differ between the two groups
(data not shown). These data indicate that
remyelination probably occurred in the
corpus callosum after acute OLG death,
although its extent was difficult to assess
given that g-ratios of myelinated and re-
myelinated axons are very similar due to
the small diameters of the majority of ax-
ons in this tract (Stidworthy et al., 2003).
Overall remyelination in our model was
not sufficient to cause functional recovery
in the experimental mice before the ex-
periment had to be terminated (Duncan
et al., 2009).
Genetically targeted cell death of adult
oligodendrocytes causes axonal damage
Next, we investigated whether the loss of
adult OLGs affected axonal integrity. We
first performed immunohistochemistry
using SMI32 antibodies that specifically
recognize a nonphosphorylated neuro-
filament epitope, in combination with an
antibody that recognizes neurofilament
M. A striking increase in immunoreactiv-
ity in the cerebellar white matter of exper-
imental mice was detected at end stage
(Fig. 6A). Consistent with these findings,
we also observed increased neuronal
staining of APP, an indicator of impaired
axonal transport (Fig. 6B), and Fluoro-
Jade C, a marker of general axonal/neuro-
nal impairment (Schmued et al., 2005),
showed increased signal intensity (Fig.
6B). Morphological observations of ax-
onal accumulation of cell organelles (Fig.
6E) and axon atrophy (Fig. 3C,D) corrob-
orated these findings. Quantitative analy-
sis of SMI32 immunoreactivity over time
revealed a tendency of axonal damage
starting with onset of clinical signs and
reaching significance at end stage (Fig.
6C). To ascertain changes at nodes of Ran-
vier, we analyzed Caspr (localized in the
paranodal axolemma) and Kv1.2 (jux-
taparanodal axolemma) by immunohis-
tochemistry on spinal cord (end stage)
longitudinal sections. Both marker pro-
teins were lost at approximately half of
nodes of Ranvier in experimental mice
(reduction: Caspr, to 49.4  3.3%, p 
0.003; Kv1.2 internodes, to 47.3 5.4%,
Figure 5. Myelin debris clearance and remyelination. A, Phagocytic cells engaged in clearance of myelin debris, as demon-
strated bymyelin debris-filled vacuoles, were frequently found in damaged tissue at end stage.B, Completely denuded axons can
be found in strongly affected tissue. C, Occasionally, thin myelin sheaths indicative of remyelination were present. D, Presence of
myelin debris in the vicinity of naked axons, likely to inhibit remyelination. E, Demyelination affecting only a selected internode
leading toheminode formation.F,G, Comparisonof theweakly affected corpus callosumbetweencontrol (F) andexperimental (G)
4
mice at end stage showing some thinnermyelin sheaths in the
latter, indicative of remyelination. Inserts show magnifica-
tions of myelinated axons of comparable size. H, Scattergram
of g-ratios in relation to axonal diameters reveals a population
of thinly myelinated axons with g-ratios0.8 specifically in
experimental animals. Note the increased number of axons
with g-ratios0.8 in experimental mice. Scale bars, 1m.
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p  0.002). In summary, these data indicate that axons are vul-
nerable to the death of adult OLGs.
Axonal damage following genetically induced loss of adult
oligodendrocytes occurs independently of the adaptive
immune system
It is currently not clear whether axonal loss in a demyelinating
disease such as MS, characterized by a maladaptive immune re-
sponse, is entirely due to inflammation or at least partially to loss
of myelin-associated trophic support. To characterize the im-
mune response to white matter damage in our experimental
mice, we first used Iba-1 immunohistology. We found wide-
spread activation of cells of the monocyte/macrophage lineage
(including microglial cells), especially within affected areas and
associated with myelin debris (Fig. 7A; supplemental Figs. 1A,
3B, available at www.jneurosci.org as supplemental material) ac-
cumulating with disease progression (Fig. 7B). Iba-1 cells were
also proliferating (supplemental Fig. 2, available at www.
jneurosci.org as supplemental material). In parallel, we observed
a widespread and pronounced increase of GFAP astrocytes
(supplemental Figs. 1B, 2, available at www.jneurosci.org as sup-
plemental material). We next looked for cells of the adaptive
Figure 6. Axonal impairment after induction of adult oligodendrocyte cell death. A, B, Animals at end stage show increased immunofluorescent staining for nonphosphorylated neurofilament
(SMI32) (A), APP and Fluoro-Jade C (B), indicative of secondary axonal damage in cb. Inset shows single confocal plane optical section of a neuron that was double positive for APP and NF-M. C,
Quantifications of SMI32 staining over the time course of disease development in cb, reaching significance in increase at end stage. D, Exemplary aberrant accumulation of organelles in axon
indicative of defective axonal transport. Data are given as mean SEM. *p 0.05, Student’s t test. Scale bars: A, B, 100m; D, 2m.
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immune system, but we did not find accu-
mulations of B-cells (B220), T-helper cells
(CD4), or T-cytotoxic cells (CD8) in
damaged or unaffected regions at end stage
(Fig. 7C). These findings suggested an intact
blood–brain barrier (BBB) in our experi-
mental mice, which we confirmed by find-
ing no detectable penetration of blood
serum albumin into brain tissue when
traced with Evans blue dye by immunoflu-
orescence (data not shown) or Evans blue
permeability assay at end stage (Fig. 7D). To
prove the absence of an adaptive immune
component to the phenotype, we crossed
the experimental mice onto a recombina-
tion activating gene-1 (RAG-1)-deficient
background (Mombaerts et al., 1992) that is
depleted of functional lymphocytes. When
ablationofOLGswas induced in thesemice,
clinical sign development was indistin-
guishable frommice with a fully functional
immune system (Fig. 7E). There were also
no significant differences in tissue vacuola-
tion (2213  58 myelin vacuoles/mm2 in
RAG-1w/w vs 2379  73 myelin vacuoles/
mm2 inRAG-10/0 at end stage, p 0.1477),
activation of phagocytic cells (5.55  0.40
Iba-1 cells/mm2 in RAG-1w/w vs 5.15 
0.58 cells/mm2 in RAG-10/0 at end stage,
p 0.6027), or axonal damage (5.01 0.55
relative SMI32 fluorescence intensity in
RAG-1w/w vs 5.14 0.74 relative SMI32 flu-
orescence intensity inRAG-10/0 at end stage,
p 0.895; 1.00 0.13 and 0.99 0.47 rel-
ative SMI32 fluorescence intensity in con-
trol animals of the respective genotype).
Together, these results suggest that the
adaptive immune system is not involved in
the pathology following genetically trig-
gered cell death of adult OLGs.
Discussion
In this article,we show that cell-intrinsic ab-
lation of adult OLGs in the intact CNS pro-
vides a highly reproducible model to
examine the biology of myelin–axon inter-
actions and tissue repair. Using this model,
we provide evidence that efficient removal
of myelin benefits from a disrupted BBB:
Without this occurring, remyelination is
poor and axons are damaged. This axonal
injury is the consequence of myelin disrup-
tion and does not require the adaptive im-
mune system. Our data therefore indicate
that protecting axons from the conse-
quences ofmyelin damage is critical, andwe
believe that fostering efficient myelin clear-
ance in concert with supporting remyelina-
tion is likely to be beneficial.
Currently available models for studying
the consequences of disrupting myelin–
axon interactions are based on gene-
specific mutations (Nave and Trapp, 2008),
Figure 7. No detectable involvement of the adaptive immune system in disease development after genetically induced adult oligo-
dendrocyte death. A, Histological staining for activated monocytic cells (Iba-1) reveals accumulation in damaged tissues of cb and bs in
experimental mice. B, Quantifications of Iba-1 cells over the time course of disease development shows increasing accumulation of
activated microglia in the severely affected cb. C, Quantifications of stainings for B220, CD4, and CD8 at end stage show no significant
increase in B- and T-cells within the brain, suggesting nomajor adaptive immune response to adult oligodendrocyte death reaching the
CNS.D, Evansbluepenetrationassay revealsno leakageof theblood–brainbarrier inexperimentalanimalsatendstage,whileprominent
influx was found in the inflammatory EAE model. E, When experimental mice are depleted of functional lymphocytes by breeding on a
RAG-1-nullbackground, symptomaticprogressionremainsunchangedcomparedwiththeRAG-1wild-typebackground.Dataaregivenas
mean SEM. inj., Injection. *p 0.05, **p 0.01, ***p 0.001, Student’s t test. Scale bars, 100m.
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induced autoimmunity against CNS components (Baxter, 2007),
and the use of various toxins (Blakemore and Franklin, 2008).
Each of these established models is valuable to study specific
aspects of the underlying mechanisms of myelin pathology, but
none allows the well defined and controlled specific ablation of
adult OLGs in the intact mouse CNS. Importantly, in the model
we describe here there are no confounding primary effects on
other cell types, including on axons, which remain concerns with
the use of toxins or immune-mediatedmodels. After induction of
genetic recombination and a comparable synchronized loss of
OLGs in all areas examined, we observed a highly reproducible
disease process with a relatively late onset and slow progression.
The first clinical disease signs coincided with myelin pathology,
includingmyelin vacuolation, whichmost likely occur due to the
decay of structurally important myelin components (Baumann
and Pham-Dinh, 2001). The occurrence of vacuoles in affected
brain areas correlatedwith the increase in T2 values in the respec-
tive ROIs observed in MRI. Myelin vacuoles increased both in
size and numbers with disease progression and were associated
with microglia activation and astrogliosis. However, phagocytic
removal of myelin was slow. This was most likely due to the BBB
remaining intact. Resident microglia would therefore appear to
be inefficient in removing myelin debris in the absence of blood-
derived macrophages or stimulation by recruited adaptive im-
mune cells (Neumann et al., 2009). Similar mechanisms have
been suggested to underlie the protracted myelin clearance in
Wallerian degeneration involving apoptotic oligodendrocyte
death after optic nerve and spinal cord injury (Vargas and Barres,
2007).
Toxin-induced demyelination in the adult rodent CNS is
characterized by brisk removal of myelin debris and efficient re-
myelination (Zhao et al., 2006). It was striking in our model that
the poor removal of myelin debris was also associated with poor
remyelination, a result consistent with earlier studies on the
remyelination-inhibitory properties of uncleared myelin debris
(Kotter et al., 2006; Baer et al., 2009). Although inhibitory toOPC
differentiation, myelin debris does not effect OPC proliferation,
which most likely accounts for the OPC proliferation that we
observed in ourmodel. Some limited remyelinationwas observed
in the corpus callosum. This area of whitematter contains almost
exclusively small-diameter, thinly myelinated axons, so it is pos-
sible that the relatively small amount of debris generated in this
region was insufficient to inhibit remyelination from occurring.
By contrast, in the deep cerebellar white matter, which contains
large heavily myelinated axons, the quantity of myelin debris is
greater andmay account for the lack of remyelination seen in this
region. Significantly, it was in the areas in which remyelination
was absent that the most severe axon pathology was observed.
Thus, we favor the hypothesis that nonefficient myelin debris
clearance, in combination with impaired remyelination, leads to
axonal damage. This impairment is not dependent on the adap-
tive immune system since the extent of both, myelin alterations
and axonal damage,was identical on an immune-deficientmouse
background. Our findings are in line with the view thatmyelinat-
ing glia provide vital protective and/or nurturing support to ax-
ons (Nave and Trapp, 2008; Nave, 2010). Nonetheless, we cannot
formally exclude direct damage contributions throughmicroglia,
astroglia, toxic effects of myelin debris, or combinations of all
these factors.
Ourmousemodel is not characterized by extensive inflamma-
tion, nor does the immune system participate in regulating the
extent of myelin vacuolation, activation of microglia, or the de-
gree of axonal damage. Thus, we expect that this model will be
valuable to study the consequences of adult OLG death on neu-
ron–glia interactions and tissue integrity without the overshad-
owing influence by the adaptive immune system. In turn, the
model allows the specific activation and modulation of regu-
latory immune and nonimmune pathways to examine, for ex-
ample, how myelin clearance and potential detrimental
consequences could be improved.
Although induction of adult OLG cell death cannot be con-
sidered to be a an accurate facsimile of all types of MS, it is
noteworthy that the observed pathology bearsmuch resemblance
with described early MS lesions that are characterized by major
OLG loss (Barnett and Prineas, 2004). Thus, these mice might be
useful to follow up on the disease mechanism in these particular
types of patients and lesions.
In summary, we present a highly reproducible animal model
of induced adult OLG cell death that has ample potential for
future studies such as axon–glia interactions, demyelination,
mechanisms of myelin debris clearance, and remyelination.
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